Femasys: Funding, Investors & Team (Oct 2026)
Femasys is a biomedical company that aims to revolutionize women's healthcare globally by creating innovative solutions and advancements that have a significant impact on clinical care in areas with limited resources. Initially focusing on reproductive health, the company's main products include FemBloc®, a non-surgical permanent birth control option, and FemaSeed™, a directed sperm delivery product for infertility treatment. Additionally, Femasys markets FemVue®, an ultrasound-based product for assessing fallopian tubes, as its main commercial priority in the United States. The company has also developed a technology platform for tissue sampling that will be marketed alongside other women-specific medical products in doctors' offices.
Femasys has raised $26.9M across 3 funding rounds on record, the most recent an undisclosed round of $12.0M announced in Nov 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Femasys Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Femasys Funding Rounds
Femasys raised $6.9M in an undisclosed round announced in Nov 2023.
1.8 years later, an undisclosed round of $8.0M was announced in Aug 2025.
3 months later, an undisclosed round of $12.0M was announced in Nov 2025.
Femasys Founders and Leadership Team
No contact details are on record for this team yet.
Femasys Funding Compared to Other Biotechnology Startups
Femasys' latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Femasys in Biotechnology and Suwanee
Companies Similar to Femasys
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Femasys Funding FAQs
What does Femasys do?
Femasys is a biomedical company that aims to revolutionize women's healthcare globally by creating innovative solutions and advancements that have a significant impact on clinical care in areas with limited resources. Initially focusing on reproductive health, the company's main products include FemBloc®, a non-surgical permanent birth control option, and FemaSeed™, a directed sperm delivery product for infertility treatment. Additionally, Femasys markets FemVue®, an ultrasound-based product for assessing fallopian tubes, as its main commercial priority in the United States. The company has also developed a technology platform for tissue sampling that will be marketed alongside other women-specific medical products in doctors' offices.
How much funding has Femasys raised?
Femasys has raised $26.9M across 3 rounds on record. The most recent is an undisclosed round of $12.0M announced in Nov 2025.
When did Femasys last raise funding?
Femasys' most recent funding round on record is an undisclosed round of $12.0M, announced in Nov 2025.
Who founded Femasys?
FundedIQ lists Kathy Lee Sepsick (Founder) at Femasys.
Where is Femasys headquartered?
Femasys is based in Suwanee, Georgia, United States.
How many employees does Femasys have?
Femasys is in the 51-100 employee band.
How does Femasys' funding compare to other Biotechnology startups?
Femasys' latest round of $12.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Femasys Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Femasys is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.